Dashboard
Manage Tickers

GNTX GENTEX CORP

Nasdaq gentex.com


$ 23.55 $ -2.68 (-10.18 %)    

Friday, 24-Oct-2025 18:57:09 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 23.64
$ 25.45
$ 23.50 x 10
$ 27.77 x 4
$ 23.45 - $ 25.75
$ 20.08 - $ 30.86
7,736,306
na
5.19B
$ 0.89
$ 12.94
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 02-25-2025 12-31-2024 10-K
4 11-01-2024 09-30-2024 10-Q
5 08-02-2024 06-30-2024 10-Q
6 05-03-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 11-03-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-22-2023 12-31-2022 10-K
12 11-04-2022 09-30-2022 10-Q
13 08-03-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-23-2022 12-31-2021 10-K
16 11-05-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 02-22-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-07-2020 06-30-2020 10-Q
22 05-08-2020 03-31-2020 10-Q
23 02-26-2020 12-31-2019 10-K
24 11-01-2019 09-30-2019 10-Q
25 08-02-2019 06-30-2019 10-Q
26 05-03-2019 03-31-2019 10-Q
27 02-22-2019 12-31-2018 10-K
28 11-02-2018 09-30-2018 10-Q
29 08-03-2018 06-30-2018 10-Q
30 05-04-2018 03-31-2018 10-Q
31 02-21-2018 12-31-2017 10-K
32 11-03-2017 09-30-2017 10-Q
33 08-04-2017 06-30-2017 10-Q
34 05-05-2017 03-31-2017 10-Q
35 02-22-2017 12-31-2016 10-K
36 11-04-2016 09-30-2016 10-Q
37 08-05-2016 06-30-2016 10-Q
38 05-05-2016 03-31-2016 10-Q
39 02-23-2016 12-31-2015 10-K
40 11-05-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-is-gentex-corporation-stock-falling-today
Why Is Gentex Corporation Stock Falling To...
10/24/2025 15:33:36

Gentex shares fall after Q3 miss; revenue below estimates, core sales down, guidance narrowed; regional weakness and tariffs pr...

Core News & Articles
12 Consumer Discretionary Stocks Moving In...
10/24/2025 12:07:38

gentex-narrows-fy2025-sales-guidance-from-2440b-2610b-to-2500b-2600b-vs-2525b-est
Gentex Narrows FY2025 Sales Guidance from ...
10/24/2025 12:02:38

Gentex (NASDAQ:GNTX) narrows FY2025 sales outlook from $2.440 billion-$2.610 billion to $2.500 billion-$2.600 billion vs $2.525...

gentex-q3-adj-eps-046-misses-047-estimate-sales-655236m-miss-664513m-estimate
Gentex Q3 Adj. EPS $0.46 Misses $0.47 Esti...
10/24/2025 12:00:52

Gentex (NASDAQ:GNTX) reported quarterly earnings of $0.46 per share which missed the analyst consensus estimate of $0.47 by 2.5...

Core News & Articles
Earnings Scheduled For October 24, 2025
10/24/2025 08:32:15

examining-the-future-gentexs-earnings-outlook
Examining the Future: Gentex's Earnings Ou...
10/23/2025 15:01:40

gain-therapeutics-to-host-oct-14-virtual-kol-event-on-gt-02287-for-parkinsons-featuring-karl-kieburtz-and-kenneth-marek
Gain Therapeutics To Host Oct 14 Virtual K...
10/09/2025 11:21:33

ubs-maintains-neutral-on-gentex-raises-price-target-to-29
UBS Maintains Neutral on Gentex, Raises Pr...
10/06/2025 16:32:58

UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and raises the price target from $28 to $29.

ubs-maintains-neutral-on-gentex-raises-price-target-to-28
UBS Maintains Neutral on Gentex, Raises Pr...
07/28/2025 22:03:43

UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and raises the price target from $23 to $28.

b-riley-securities-maintains-buy-on-gentex-raises-price-target-to-32
B. Riley Securities Maintains Buy on Gente...
07/28/2025 17:20:39

B. Riley Securities analyst Josh Nichols maintains Gentex (NASDAQ:GNTX) with a Buy and raises the price target from $28 to $32.

baird-maintains-neutral-on-gentex-raises-price-target-to-30
Baird Maintains Neutral on Gentex, Raises ...
07/28/2025 14:44:02

Baird analyst David Leiker maintains Gentex (NASDAQ:GNTX) with a Neutral and raises the price target from $26 to $30.

us-stocks-hit-new-highs-as-magnificent-seven-reach-19-trillion-whats-moving-markets-friday
US Stocks Hit New Highs As Magnificent Sev...
07/25/2025 17:33:32

Wall Street looked set to close the week on a high note, with large-cap benchmarks pushing higher in Friday's midday tradin...

why-gentex-stock-is-gaining-today
Why Gentex Stock Is Gaining Today?
07/25/2025 15:28:07

Gentex shares jumped 15% after beating Q2 estimates, boosting full-year sales guidance, and posting strong margins despite weak...

boston-beer-posts-better-than-expected-earnings-joins-scholastic-deckers-outdoor-saia-and-other-big-stocks-moving-higher-on-friday
Boston Beer Posts Better-Than-Expected Ear...
07/25/2025 14:31:45

gentex-to-withhold-2026-revenue-guidance-amid-geopolitical-tariff-and-customer-sourcing-uncertainties
Gentex To Withhold 2026 Revenue Guidance A...
07/25/2025 12:08:51

gentex-raises-fy2025-sales-guidance-from-2150b-2320b-to-2440b-2610b-vs-2435b-est
Gentex Raises FY2025 Sales Guidance from $...
07/25/2025 12:07:04

Gentex (NASDAQ:GNTX) raises FY2025 sales outlook from $2.150 billion-$2.320 billion to $2.440 billion-$2.610 billion vs $2.435 ...

gentex-corporation-reports-q2-adjusted-eps-of-047-a-27-yoy-increase-when-adjusted-for-acquisition-related-expenses-and-severance-costs
Gentex Corporation Reports Q2 Adjusted Eps...
07/25/2025 12:05:08

gentex-q2-eps-043-beats-037-estimate-sales-657858m-beat-604874m-estimate
Gentex Q2 EPS $0.43 Beats $0.37 Estimate, ...
07/25/2025 12:02:42

Gentex (NASDAQ:GNTX) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.37 by 16.22...

Core News & Articles
Earnings Scheduled For July 25, 2025
07/25/2025 08:32:12

earnings-preview-for-gentex
Earnings Preview For Gentex
07/24/2025 15:01:12

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION